COVID-19 Infection in Patients With Chronic Pulmonary Diseases.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Sohag University
- Enrollment
- 100
- Primary Endpoint
- Effect of COVID-19 on patients with chronic pulmonary diseases
- Last Updated
- 4 years ago
Overview
Brief Summary
This study aims to assess the clinical presentation, radiological patterns and outcome of COVID-19 infection in patients with chronic pulmonary disease.
Inter-relationship between the severity of COVID-19 infection and chronic pulmonary diseases.
Detailed Description
The COVID-19 pandemic has led to many difficulties with the diagnosis and routine management of chronic pulmonary diseases such as COPD, Bronchial asthma, ILD and Bronchiectasis as well as raising concerns about the management and outcomes for patients with these diseases who develop COVID-19. Although there is conflicting evidence on whether patients with chronic respiratory diseases are more susceptible to COVID-19, these patients exhibit a more severe presentation and higher mortality compared with those without chronic respiratory diseases.
Investigators
Mostafa Mahmoud Elsayed
Principal Investigator
Sohag University
Eligibility Criteria
Inclusion Criteria
- •Subjects with confirmed diagnosis of COVID-19 infection by:
- •RT-PCR And Chest Computed tomography and laboratoty investigations. Patients with chronic chest disease including (COPD, bronchial asthma, ILD, bronchiectasis).
Exclusion Criteria
- •Those who are diagnosed with viral pneumonia caused by viruses other than COVID-
- •Those who are not confirmed to be COVID-19 with PCR or by radiological and laboratory investigations.
Outcomes
Primary Outcomes
Effect of COVID-19 on patients with chronic pulmonary diseases
Time Frame: 2 weeks after patient confirmation of infection by COVID-19